MoreNeutrophil- to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis

참고문헌 (16)

1. Wong ND, "Epidemiological studies of CHD and the evolution of preventive cardiology", Nat Rev Cardiol, 11, pp.276~289 (2014)
2. "Promoting cardiovascular health in the developing world: a critical challenge to achieve global health" (2010), National Academies Press
3. Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
4. Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", N Engl J Med, 352, pp.1685~1695 (2005)
5. Danesh J, "C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease", N Engl J Med, 350, pp.1387~1397 (2004)
6. Engström G, "Fatality of future coronary events is related to inflammationsensitive plasma proteins: a population-based prospective cohort study", Circulation, 110, pp.27~31 (2004)
7. 김봉준, "The Combined Impact of Neutrophil-to-Lymphocyte Ratio and Type 2 Diabetic Mellitus on Significant Coronary Artery Disease and Carotid Artery Atherosclerosis", Journal of Cardiovascular Ultrasound, 24(2), pp.115~122 (2016), 한국심초음파학회
8. Ridker PM, "Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events", N Engl J Med, 347, pp.1557~1565 (2002)
9. Ridker PM, "Clinical application of C-reactive protein for cardiovascular disease detection and prevention", Circulation, 107, pp.363~369 (2003)
10. Morrow DA, "C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes:a TIMI 11A substudy. Thrombolysis in Myocardial Infarction", J Am Coll Cardiol, 31, pp.1460~1465 (1998)
11. Mueller C, "Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients", Circulation, 105, pp.1412~1415 (2002)
12. Bhatt DL, "Need to test the arterial inflammation hypothesis", Circulation, 106, pp.136~140 (2002)
13. Ridker PM, "C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year followup of 14 719 initially healthy American women", Circulation, 107, pp.391~397 (2003)
14. Pradhan AD, "Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study", JAMA, 288, pp.980~987 (2002)
15. Wensley F, "Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data", BMJ, 342, pp.d548~ (2011), C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC)
16. Brunner EJ, "Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream.", PLoS Med, 5, pp.e155~ (2008)

관련 논문AI추천